BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 11094650)

  • 1. Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women.
    Contreras I; Parra D
    Am J Health Syst Pharm; 2000 Nov; 57(21):1963-8; quiz 1969-71. PubMed ID: 11094650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy (HRT) and ischaemic heart disease: getting to the heart of the matter.
    Chew S; Ng SC
    Singapore Med J; 2002 Jan; 43(1):41-4. PubMed ID: 12008777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III).
    Herrington DM; Fong J; Sempos CT; Black DM; Schrott HG; Rautaharju P; Bachorik PS; Blumenthal R; Khan S; Wenger NK
    Am Heart J; 1998 Jul; 136(1):115-24. PubMed ID: 9665228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
    Grady D; Herrington D; Bittner V; Blumenthal R; Davidson M; Hlatky M; Hsia J; Hulley S; Herd A; Khan S; Newby LK; Waters D; Vittinghoff E; Wenger N;
    JAMA; 2002 Jul; 288(1):49-57. PubMed ID: 12090862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormone replacement therapy of menopause, heart and blood vessels].
    Kuttenn F; Gerson M
    Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogens should not be initiated for the secondary prevention of coronary artery disease: a debate.
    Hulley S
    Can J Cardiol; 2000 Aug; 16 Suppl E():10E-12E. PubMed ID: 10906618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The choice of hormone replacement therapy or statin therapy in the treatment of hyperlipidemic postmenopausal women.
    Seed M
    Atheroscler Suppl; 2002 May; 3(1):53-63. PubMed ID: 12044587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy in clinical cardiology.
    Bittner V
    Cardiol Rev; 2000; 8(1):57-64. PubMed ID: 11174874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormones and heart disease in women: Heart and Estrogen/Progestin Replacement Study in perspective.
    Barrett-Connor E; Stuenkel C
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1848-53. PubMed ID: 10372673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy and coronary heart disease in women: a review of the evidence.
    Low AK; Russell LD; Holman HE; Shepherd JM; Hicks GS; Brown CA
    Am J Med Sci; 2002 Oct; 324(4):180-4. PubMed ID: 12385489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study.
    McPherson R
    Can J Cardiol; 2000 Jan; 16 Suppl A():14A-9A. PubMed ID: 10653926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy and the association with coronary heart disease and overall mortality: clinical application of the timing hypothesis.
    Hodis HN; Mack WJ
    J Steroid Biochem Mol Biol; 2014 Jul; 142():68-75. PubMed ID: 23851166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estrogens for prevention of coronary heart disease?].
    Meinertz T
    Herz; 1997 Jun; 22(3):151-7. PubMed ID: 9303898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure control and hormone replacement therapy in postmenopausal women at risk for coronary heart disease.
    McCubbin JA; Helfer SG; Switzer FS; Price TM
    Am Heart J; 2002 Apr; 143(4):711-7. PubMed ID: 11923810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal women and cardiovascular risk: impact of hormone replacement therapy.
    Rosano GM; Fini M
    Cardiol Rev; 2002; 10(1):51-60. PubMed ID: 11790270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.
    Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH
    Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary and secondary prevention of cardiovascular events through hormone replacement therapy (HRT)].
    Pilz H
    Wien Med Wochenschr; 2005 Sep; 155(17-18):397-403. PubMed ID: 16392437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary heart disease and hormone replacement therapy after the menopause.
    Hodis HN; Mack WJ
    Climacteric; 2009; 12 Suppl 1():71-5. PubMed ID: 19811246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should progestins be blamed for the failure of hormone replacement therapy to reduce cardiovascular events in randomized controlled trials?
    Koh KK; Sakuma I
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1171-9. PubMed ID: 15130916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.